Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Avian Dis ; 59(2): 249-54, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26473675

RESUMO

With the aim of assessing the antigenic characteristics of a circulating pool of fowlpox virus (FPV) that exists in the backyard poultry system in India, one of the field isolates generated was characterized by in vitro immunologic techniques. FPV was isolated from clinically positive fowlpox cases (n  =  10) from the Jhargram (West Midnapur district) and Kakdwip (South 24 Pargana district) areas of West Bengal State, India. Initially, FPV-specific PCR was performed for confirmation of the samples. Isolation of FPV was done using embryonated chicken eggs and the choreoallantoic membrane route. Subsequently, FPV antigen was prepared from chicken embryo fibroblast cell culture-adapted field isolate. Biologic transmission of FPV was performed in Rhode Island red chickens experimentally to assess humoral and cell-mediated immune (CMI) responses. High level of anti-FPV antibodies were observed in test birds as assessed by indirect ELISA. Seroreactive polypeptides (B-cell antigens) of FPV antigen with molecular weights of 44.5, 66.5, 75, 90.5, and 99 kDa were detected by western blot analysis. Significant increases in CMI responses were observed in inoculated chickens as assessed by lymphocyte proliferation assay, cytotoxicity assay, and T-cell immunoblotting. The predominant T-cell antigen of FPV detected had a molecular weight of 66.5 kDa. The present study revealed the antigenic characteristics of FPV that exists in backyard poultry system in West Bengal for the first time, thus exploring the rationality of designing future T- and B-cell vaccines against fowlpox.


Assuntos
Antígenos Virais/imunologia , Linfócitos B/fisiologia , Galinhas , Vírus da Varíola das Aves Domésticas/metabolismo , Varíola Aviária/imunologia , Linfócitos T/fisiologia , Animais , Antígenos Virais/metabolismo , Varíola Aviária/epidemiologia , Índia/epidemiologia
2.
Chem Commun (Camb) ; 52(7): 1432-5, 2016 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-26647115

RESUMO

Decarboxylative coupling reactions to date require a stoichiometric oxidant (such as copper and silver salts) for decarboxylation purposes along with a metal catalyst (e.g. palladium) for cross-coupling. In this communication, an economic and sustainable approach by using a simple copper salt was developed in the presence of molecular oxygen as the sole oxidant. A wide range of 5-membered heteroarenes undergo aryl-heteroaryl cross-coupling with electron deficient aryl carboxylic acids.

3.
Sci Rep ; 6: 21840, 2016 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-26908015

RESUMO

PURPOSE: Successful repair of a damaged corneal surface is a great challenge and may require the use of a scaffold that supports cell growth and differentiation. Amniotic membrane is currently used for this purpose, in spite of its limitations. A thin transparent silk fibroin film from non-mulberry Antheraea mylitta (Am) has been developed which offers to be a promising alternative. The silk scaffolds provide sufficient rigidity for easy handling, the scaffolds support the sprouting, migration, attachment and growth of epithelial cells and keratocytes from rat corneal explants; the cells form a cell sheet, preserve their phenotypes, express cytokeratin3 and vimentin respectively. The films also support growth of limbal stem cell evidenced by expression of ABCG2. The cell growth on the silk film and the amniotic membrane is comparable. The implanted film within the rabbit cornea remains transparent, stable. The clinical examination as well as histology shows absence of any inflammatory response or neovascularization. The corneal surface integrity is maintained; tear formation, intraocular pressure and electroretinography of implanted eyes show no adverse changes. The silk fibroin film from non-mulberry silk worms may be a worthy candidate for use as a corneal scaffold.


Assuntos
Materiais Biocompatíveis/farmacologia , Córnea/fisiologia , Fibroínas/farmacologia , Regeneração/efeitos dos fármacos , Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP/metabolismo , Âmnio/transplante , Animais , Materiais Biocompatíveis/química , Adesão Celular/efeitos dos fármacos , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Córnea/patologia , Córnea/ultraestrutura , Ceratócitos da Córnea/citologia , Ceratócitos da Córnea/efeitos dos fármacos , Ceratócitos da Córnea/metabolismo , Eletrorretinografia , Fibroínas/química , Pressão Intraocular/fisiologia , Queratina-3/metabolismo , Microscopia Eletrônica de Varredura , Microscopia de Fluorescência , Mariposas/metabolismo , Coelhos , Ratos , Ratos Sprague-Dawley , Refratometria , Vimentina/metabolismo
4.
J Mol Med (Berl) ; 93(10): 1095-106, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25877858

RESUMO

UNLABELLED: Corneal neovascularization is a leading cause for compromised vision. Therapeutic prevention of corneal neovascularization is a major clinical challenge, and there is a compelling need to seek effective and safe therapy for this pathology. This study is aimed to evaluate curcumin nanoparticle for prevention of corneal neovascularization. MePEG-PCL nanoparticles were successfully prepared and characterized. The nanoparticle of curcumin has shown increased efficiency in preventing angiogenic sprouting in vitro. Topical delivery of curcumin nanoparticle in the eye showed enhanced retention of curcumin in the cornea, and significant improvement in prevention of corneal neovascularization over free curcumin as graded clinically and by histopathology; suppression in the expression of VEGF, inflammatory cytokines, and MMP was evidenced in the treated cornea. Curcumin inhibited NFκB in LPS-induced corneal cells. Histopathology and scanning electron microscopy showed absence of any adverse change in the corneal structure following application of curcumin nanoparticle. Therefore, we conclude that curcumin nanoparticle can be a potential candidate for prevention of corneal neovascularization. KEY MESSAGE: • Curcumin nanoparticles show enhanced retention of curcumin in the cornea. • Curcumin NPs suppress the expression of VEGF, inflammatory cytokines, and MMP. • Curcumin NPs prevent corneal neovascularization by suppressing the NFκB pathway. • Curcumin NPs may be a promising candidate for prevention of corneal neovascularization.


Assuntos
Inibidores da Angiogênese/administração & dosagem , Neovascularização da Córnea/tratamento farmacológico , Curcumina/administração & dosagem , Portadores de Fármacos/administração & dosagem , Inibidores da Angiogênese/farmacologia , Inibidores da Angiogênese/uso terapêutico , Animais , Aorta Torácica/efeitos dos fármacos , Aorta Torácica/fisiologia , Células Cultivadas , Córnea/efeitos dos fármacos , Córnea/metabolismo , Córnea/ultraestrutura , Ceratócitos da Córnea/efeitos dos fármacos , Ceratócitos da Córnea/metabolismo , Neovascularização da Córnea/metabolismo , Neovascularização da Córnea/patologia , Curcumina/farmacologia , Curcumina/uso terapêutico , Portadores de Fármacos/farmacologia , Portadores de Fármacos/uso terapêutico , Feminino , Proteínas I-kappa B/metabolismo , Interleucina-1beta/genética , Lipopolissacarídeos , Masculino , Camundongos , Inibidor de NF-kappaB alfa , NF-kappa B/metabolismo , Nanopartículas/administração & dosagem , Nanopartículas/química , Nanopartículas/uso terapêutico , Poliésteres/química , Polietilenoglicóis/química , Ratos Sprague-Dawley , Fator de Necrose Tumoral alfa/genética , Fator A de Crescimento do Endotélio Vascular/genética
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa